LOCUS PHARMACEUTICALS

locus-pharmaceuticals-logo

Locus Pharmaceuticals, Inc. develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs. Its fragment-based computational drug design technology is used for the discovery and development of compounds for the treatment of unmet medical needs. The company has a computational drug design technology, which is used to develop a pipeline of drug development candidates, including direct and allosteric kinase inhibitors for cancer and inflammation diseases. Locus Pharmaceuticals, Inc. was formerly known as Locus Discovery, Inc. The company was incorporated in 1998 and is based in Blue Bell, Pennsylvania. Locus Pharmaceuticals, Inc. is a former subsidiary of Sarnoff Corporation.

#Financial #Website #More

LOCUS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
1998-01-01

Address:
Blue Bell, Pennsylvania, United States

Country:
United States

Website Url:
http://www.locuspharma.com

Total Employee:
11+

Status:
Closed

Contact:
1-888-600-4908

Email Addresses:
[email protected]

Total Funding:
139.63 M USD

Technology used in webpage:
SPF DMARC Digital Ocean GoDaddy Email Mandrill DNS Made Easy DNS SparkPost


Acquisitions List

Date Company Article Price
2004-07-21 Protein Mechanics Protein Mechanics acquired by Locus Pharmaceuticals N/A

Investors List

l-capital-partners_image

L Capital Partners

L Capital Partners investment in Series E - Locus Pharmaceuticals

sr-one_image

SR One

SR One investment in Series E - Locus Pharmaceuticals

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Series E - Locus Pharmaceuticals

tredegar-investments_image

Tredegar Investments

Tredegar Investments investment in Series C - Locus Pharmaceuticals

cooper-hill-partners_image

Cooper Hill Partners

Cooper Hill Partners investment in Series C - Locus Pharmaceuticals

prism-venture-management_image

Prism Venture Management

Prism Venture Management investment in Series C - Locus Pharmaceuticals

johnson-johnson-development-corporation_image

Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation investment in Series C - Locus Pharmaceuticals

delphi-ventures_image

Delphi Ventures

Delphi Ventures investment in Series C - Locus Pharmaceuticals

dresdner-kleinwort_image

Dresdner Kleinwort

Dresdner Kleinwort investment in Series C - Locus Pharmaceuticals

johnson-johnson-development-corporation_image

Johnson & Johnson Development Corporation

Johnson & Johnson Development Corporation investment in Series B - Locus Pharmaceuticals

Official Site Inspections

http://www.locuspharma.com

  • Host name: box.irsa-uscr.org
  • IP address: 138.197.162.211
  • Location: Toronto Canada
  • Latitude: 43.6547
  • Longitude: -79.3623
  • Timezone: America/Toronto
  • Postal: M5A

Loading ...

More informations about "Locus Pharmaceuticals" on Search Engine